Abstract 7189: EED inhibitor APG-5918 renders vulnerability to immunotherapy by rewiring sphingolipid metabolism via nSMase2-ceramide pathway in pancreatic cancer

Authors: Jing Yang, Fan Chen, Qiuyun Luo, Mingyu Lai, Jiachen Lu, Dajun Yang, Miaozhen Qiu

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-7189

Source: Full article